Journal: Molecular Medicine Reports
Article Title: Abnormal differentiation of stem cells into enteroendocrine cells in rats with DSS-induced colitis
doi: 10.3892/mmr.2017.6266
Figure Lengend Snippet: Densities of (A) Msi1-, (B) Math-1, (C) Neurog3- (D) and NeuroD1-immunoreactive cells in the control, DSS, DSS-G and DSS-Q groups. *P<0.001. DSS, dextran sulfate sodium-induced colitis vehicle-treated group; DSS-G, 3-[(dodecylthiocarbonyl)-methyl]-glutarimide-treated DSS group; DSS-Q, dehydroxymethylepoxyquinomicin-treated DSS group; Msi1, Musashi 1; Neurog3, neurogenin 3; NeuroD1, neurogenic differentiation D1.
Article Snippet: The sections were incubated with the following primary antibodies for 32 min at 37°C: Monoclonal mouse anti-N-terminal of purified chromogranin A (CgA; 1:1,500; cat. no. M869; Dako Denmark A/S, Glostrup, Denmark); polyclonal rabbit anti-residues 5–21 [APQPGLASPDSPHDPCK] of the human, mouse and rat Musashi 1 (Msi1) protein (1:100; cat. no. NB100-1759; R&D Systems Europe, Abingdon, UK); polyclonal rabbit anti-synthetic peptide surrounding amino acid 190 of human Math-1 (1:50; code no. 3658-100; BioVision, Inc., Milpitas, CA, USA); polyclonal rabbit anti-KLH-conjugated synthetic peptide between 40–69 amino acids from the N-terminal region of human Neurog3 (1:50; cat. no. PA5-11893, Thermo Fisher, Oslo, Norway); and polyclonal rabbit anti-recombinant full-length human neurogenic differentiation D1 (NeuroD1; 1:50; cat. no. PA5-47381; Thermo Fisher).
Techniques: